These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6548074)

  • 1. Circulating vitamin D metabolites and hypercalcaemia of malignancy.
    Ralston SH; Cowan RA; Robertson AG; Gardner MD; Boyle IT
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):556-63. PubMed ID: 6548074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
    Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
    Walls J; Ratcliffe WA; Howell A; Bundred NJ
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
    Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
    Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
    Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypocalciuric hypercalcaemia: observations on vitamin D metabolism and parathyroid function.
    Davies M; Adams PH; Berry JL; Lumb GA; Klimiuk PS; Mawer EB; Wain D
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):210-5. PubMed ID: 6314724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.
    Hutchesson AC; Bundred NJ; Ratcliffe WA
    Postgrad Med J; 1995 Jan; 71(831):28-31. PubMed ID: 7708588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
    Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
    Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic tests of parathyroid function for diagnosis of primary hyperparathyroidism in malignancy.
    Ljunghall S; Benson L; Rastad J; Wide L; Akerström G
    Clin Endocrinol (Oxf); 1987 Aug; 27(2):163-70. PubMed ID: 3117451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of hypercalcemia. Significance of the determination of intact parathyroid hormone for differential diagnosis].
    Blind E; Raue F; Zisterer A; Kohl B; Ziegler R
    Dtsch Med Wochenschr; 1990 Nov; 115(46):1739-45. PubMed ID: 2226185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of plasma parathyroid hormone in the differential diagnosis of hypercalcemias associated with malignant tumors].
    Gasser AB; Burckhardt P
    Schweiz Med Wochenschr; 1978 Jul; 108(27):1031-4. PubMed ID: 663597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol in dogs with hypercalcaemia.
    Gerber B; Hauser B; Reusch CE
    Vet Res Commun; 2004 Nov; 28(8):669-80. PubMed ID: 15609867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum parathyroid hormone related protein and 1,25-dihydroxycholecalciferol in hypercalcaemia associated with adult T-cell leukaemia-lymphoma.
    Johnston SR; Hammond PJ
    Postgrad Med J; 1992 Sep; 68(803):753-5. PubMed ID: 1480540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperparathyroidism or hypercalcaemia of malignancy?
    Birkeland KI; Gallefoss F; Olsson S; Haug E
    Scand J Clin Lab Invest; 1992 Jun; 52(4):347-9. PubMed ID: 1439519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of assessing parathyroid hormone-like activity in a case of extreme hypercalcaemia.
    Ranganath L; Jamal H; Jones L; Goddard PF
    J Clin Pathol; 1998 Mar; 51(3):257-8. PubMed ID: 9659276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
    Schömig M; Ritz E
    Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immobilisation hypercalcaemia. 1 case (author's transl)].
    Baglin A; Goupil A; Lortat-Jacob A; Arfi S; Gueris J; Milhaud G; Benoit J
    Nouv Presse Med; 1978 Feb; 7(6):453-5. PubMed ID: 634783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolites in idiopathic infantile hypercalcaemia.
    McGraw ME
    Arch Dis Child; 1986 Dec; 61(12):1246. PubMed ID: 3813624
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous calcitriol lowers serum calcium concentrations in uraemic patients with severe hyperparathyroidism and hypercalcaemia.
    Hamdy NA; Brown CB; Kanis JA
    Nephrol Dial Transplant; 1989; 4(6):545-8. PubMed ID: 2507976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.